CPB three-lens brief
Evidence-based stock research on CPB. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Underperforming SPY by 21.8pp over 30 days. · Trading at 4% of its 52-week range — deep in the lower band.
- Trading at 4% of its 52-week range — deep in the lower band.
- Underperforming SPY by 21.8pp over 30 days.
- P/E of 11.1 — trading at a value multiple.
- Analyst mean target $23.53 — 15% above current (17 analysts).
- Debt-to-equity of 185.0 — balance-sheet-heavy.
CPB closed at $20.39 (0.00%) as of 2026-05-13. Market cap: $6.08B. P/E (trailing) 11.1. Positives: p/E of 11.1 — trading at a value multiple.; analyst mean target $23.53 — 15% above current (17 analysts).. Concerns: trading at 4% of its 52-week range — deep in the lower band.; underperforming SPY by 21.8pp over 30 days.. Last quarter: Revenue $2.56B, net income $145.00M, free cash flow $862.50M.
Why three lenses on CPB, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CPBacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CPB" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CPB brief"></iframe>